Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Short-term Investments (2016 - 2025)

Ptc Therapeutics (PTCT) has 13 years of Short-term Investments data on record, last reported at $960.7 million in Q4 2025.

  • For Q4 2025, Short-term Investments rose 166.88% year-over-year to $960.7 million; the TTM value through Dec 2025 reached $960.7 million, up 166.88%, while the annual FY2025 figure was $960.7 million, 166.88% up from the prior year.
  • Short-term Investments reached $960.7 million in Q4 2025 per PTCT's latest filing, down from $1.0 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.0 billion in Q3 2025 and bottomed at $118.8 million in Q1 2023.
  • Average Short-term Investments over 5 years is $487.8 million, with a median of $441.1 million recorded in 2022.
  • Peak YoY movement for Short-term Investments: tumbled 77.58% in 2022, then skyrocketed 275.89% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $583.7 million in 2021, then crashed by 77.58% to $130.9 million in 2022, then skyrocketed by 116.04% to $282.7 million in 2023, then rose by 27.32% to $360.0 million in 2024, then skyrocketed by 166.88% to $960.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $960.7 million in Q4 2025, $1.0 billion in Q3 2025, and $971.8 million in Q2 2025.